Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intravenous plus oral tranexamic acid for blood loss in primary hip and knee replacement
ISRCTN58790500Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Jul 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in Bleeding (3 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Indirectly calculated blood loss at 48 hours post-surgery. Started Jul 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on ISRCTN58790500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN58790500.